NEA (New Enterprise Associates)
NEA is one of the world's largest and most active venture capital firms, with over 45 years of history. Their healthcare practice is one of the most established in the industry, backing transformative companies across therapeutics, healthcare IT, and medical devices.
Website
https://www.nea.comLocation
Menlo Park, California, USA
Founded
1977
AUM
$25B+
Investment Range
$1M - $200M+
Portfolio Companies
1
Focus
generalist
Fund Stages
seed, series-a, series-b, series-c, growth
Investment Thesis
NEA invests in technology and healthcare companies at all stages of growth. Their healthcare strategy spans therapeutics, medical devices, and healthcare IT, focusing on companies that can fundamentally improve patient outcomes and transform healthcare delivery through innovation.
Team
Partners / Managing Directors (Health & Bio Focus)
- Scott Sandell - Managing General Partner
- Carmen Chang - General Partner (Healthcare)
- Ed Mathers - Partner (Healthcare)
- Forest Baskett - General Partner
Other Key Team Members
- Ali Behbahani, MD - General Partner
- Mohamad Makhzoumi - General Partner
Focus Areas
- Therapeutics (oncology, immunology, rare diseases)
- Digital health
- Healthcare IT
- Medical devices
- Diagnostics
- Healthcare services
Notable Exits
- Tempus - IPO (2024, precision medicine AI - seed investor)
- Intuitive Surgical - IPO (surgical robotics)
- Immunomedics - Acquired by Gilead (2020, $21B)
- Moderna - Early investor (mRNA therapeutics)
Sources
- https://www.nea.com
- https://www.nea.com/team
- https://www.nea.com/portfolio?category=digital-health
- PitchBook
- SEC filings
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Tempus AI | Chicago, Illinois, USA | 2015 | genomics-sequencingai-drug-discovery+4 |